Literature DB >> 3491341

Symptomatic progressive ventriculomegaly in hydrocephalics with patent shunts and antisiphon devices.

D C McCullough.   

Abstract

The antisiphon device (ASD) was designed to prevent excessive negative intracranial pressure and overdrainage with cerebrospinal fluid shunts. It has been recommended for prevention of slit ventricles and extreme shunt dependency. It was used by the author in 40 children and young adults who had low pressure headaches or were judged to be at risk for the development of subdural hematomas because of extreme hydrocephalus, relatively fixed head size, or tall stature. Nine patients encountered problems with adverse symptoms in spite of shunt patency. Four had alarming neurological symptoms of coma or severe headaches after incorporation of ASDs in ventriculoperitoneal shunt systems. With patients in the horizontal position, shunt patency was documented but computed tomography revealed progressive ventriculomegaly when they were kept erect. Symptoms abated and ventricular size diminished after conversion to proximal medium pressure diaphragm or spring-ball valve systems without ASDs. Because long shunt systems with ASDs require adequate hydrostatic columns to initiate flow when patients are erect, it is theorized that such symptoms could have been prevented by placing ASDs farther downstream from the cerebral ventricles.

Entities:  

Mesh:

Year:  1986        PMID: 3491341     DOI: 10.1227/00006123-198610000-00019

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

1.  The dual-switch valve. A new hydrostatic valve for the treatment of hydrocephalus.

Authors:  C Sprung; C Miethke; H A Trost; W R Lanksch; D Stolke
Journal:  Childs Nerv Syst       Date:  1996-10       Impact factor: 1.475

2.  Clinical experience with a pressure-adjustable valve SOPHY in the management of hydrocephalus.

Authors:  C B Lumenta; N Roosen; U Dietrich
Journal:  Childs Nerv Syst       Date:  1990-08       Impact factor: 1.475

3.  Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group.

Authors:  J M Drake; J Kestle
Journal:  Childs Nerv Syst       Date:  1996-08       Impact factor: 1.475

4.  Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices.

Authors:  A Aschoff; P Kremer; C Benesch; K Fruh; A Klank; S Kunze
Journal:  Childs Nerv Syst       Date:  1995-04       Impact factor: 1.475

5.  Risks of using siphon-reducing devices.

Authors:  P Kremer; A Aschoff; S Kunze
Journal:  Childs Nerv Syst       Date:  1994-05       Impact factor: 1.475

6.  Clinical experience with a new pressure-adjustable shunt valve.

Authors:  A Reinprecht; T Czech; W Dietrich
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Importance of anti-siphon devices in the treatment of pediatric hydrocephalus.

Authors:  K Tokoro; Y Chiba; H Abe; N Tanaka; A Yamataki; H Kanno
Journal:  Childs Nerv Syst       Date:  1994-05       Impact factor: 1.475

8.  The Delta Valve: a physiologic shunt system.

Authors:  D A Watson
Journal:  Childs Nerv Syst       Date:  1994-05       Impact factor: 1.475

9.  Slit-ventricle syndrome in shunt operated children.

Authors:  O Major; I Fedorcsák; L Sipos; P Hantos; E Kónya; I Dobronyi; E Paraicz
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  The incidence and management of the slit ventricle syndrome.

Authors:  W Serlo; A L Saukkonen; E Heikkinen; L von Wendt
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.